Catalyst Wire Dossier Catalyst Wire Dossier

Fiasp (faster-acting insulin aspart)

insulin aspart, faster-acting formulation · Novo Nordisk
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fiasp (faster-acting insulin aspart), covering 2017-02-17 to 2017-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects [Phase 1]

See pricing